Restasis and Tagamet drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Restasis (cyclosporine) and Tagamet (cimetidine). Common drug interactions include cellulitis among females and feeling hot among males.

The phase IV clinical study analyzes what interactions people have when they take Restasis and Tagamet. It is created by eHealthMe based on reports of 32 people who take the same drugs from the FDA, and is updated regularly.

What is Restasis?

Restasis has active ingredients of cyclosporine. It is often used in dry eyes. eHealthMe is studying from 35,199 Restasis users. Check the latest studies of Restasis.

What is Tagamet?

Tagamet has active ingredients of cimetidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 9,011 Tagamet users. Check the latest studies of Tagamet.



On Aug, 05, 2026

32 people who take Restasis and Tagamet together, and have interactions are studied.

Restasis and Tagamet drug interactions.

What are the common drug interactions of Restasis and Tagamet, by gender? *:

female:

  1. Cellulitis (infection under the skin)
  2. Confusional state
  3. Hypotension (abnormally low blood pressure)
  4. Nausea (feeling of having an urge to vomit)
  5. Osteomyelitis (infection of bone)
  6. Pyrexia (fever)
  7. Renal failure acute (rapid kidney dysfunction)
  8. Supraventricular extrasystoles (premature electrical impulse in the heart, generated above the level of the ventricle)
  9. Urinary tract infection
  10. Visual acuity reduced (reduced clearness of vision)

male:

  1. Feeling hot
  2. Cardiac procedure complication
  3. Eye pain
  4. Hepatomegaly (abnormal enlargement of the liver)

What are the common drug interactions of Restasis and Tagamet, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Abscess (pus)
  2. Anaemia of chronic disease
  3. Anxiety
  4. Arrhythmia supraventricular (irregular heartbeat supraventricular origin)
  5. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  6. Asthenia (weakness)
  7. Back pain
  8. Blood creatinine increased
  9. Blood glucose increased
  10. Blood pressure fluctuation

20-29:

  1. Asthenia (weakness)
  2. Back pain
  3. Blood creatinine increased
  4. Blood urea increased
  5. Bone disorder
  6. Bone pain
  7. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  8. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
  9. Cardiac failure congestive
  10. Cardiomyopathy (weakening of the heart muscle)

30-39:

n/a

40-49:

  1. Blood pressure increased
  2. Cardiac flutter (abnormal heart rhythm)
  3. Chest pain
  4. Chronic kidney disease
  5. Heart rate increased
  6. Renal failure (kidney dysfunction)

50-59:

n/a

60+:

  1. Pain
  2. Anxiety
  3. Pyrexia (fever)
  4. Renal failure acute (rapid kidney dysfunction)
  5. Supraventricular extrasystoles (premature electrical impulse in the heart, generated above the level of the ventricle)
  6. Urinary tract infection
  7. Visual acuity reduced (reduced clearness of vision)
  8. Vomiting
  9. Abscess (pus)
  10. Anaemia of chronic disease

What are the existing conditions these people have? *

  1. Multiple Allergies (allergy to multiple agents): 4 people, 12.50%
  2. Pain: 3 people, 9.38%
  3. Osteoporosis (bones weak and more likely to break): 3 people, 9.38%
  4. High Blood Pressure: 3 people, 9.38%
  5. Sinusitis (inflammation of sinus): 2 people, 6.25%
  6. Parkinson's Disease: 2 people, 6.25%
  7. Neuralgia (pain in one or more nerves): 2 people, 6.25%
  8. Inflammation: 2 people, 6.25%
  9. Infection: 2 people, 6.25%
  10. Hypokalemia (low potassium): 2 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Restasis and Tagamet?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Restasis and Tagamet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Restasis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Tagamet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Restasis and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tagamet and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on cyclosporine and cimetidine (the active ingredients of Restasis and Tagamet, respectively), and Restasis and Tagamet (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: